Lynelle HochPresident, Cell Therapy Organization at Bristol Myers SquibbSpeaker
Profile
For over 25 years, I’ve had the opportunity to explore new and uncharted innovations at Bristol Myers Squibb (BMS), working with teams across therapeutic areas and functions globally. Today, in my role as President, Cell Therapy Organization, I have the pleasure of working with a team of leading pioneers who are aiming to unlock the full promise of cell therapy and advance patient health around the world.
I believe that the power of diverse teams can make the impossible possible. Whether it’s overcoming scientific challenges, scaling CAR T treatments, or acting as a champion and mentor for others, collaboration is key to solving the most complex problems across our industry. Together, our team is providing patients hope where there otherwise is none.
Agenda Sessions
Capital Markets and Commercial Insights: Navigating Opportunities and Challenges in Cell and Gene Therapies
, 09:00View Session